Supercharge Your Innovation With Domain-Expert AI Agents!

Preparation method of brimonidine tartrate impurity E

A technology for brimonidine tartrate and impurities, which is applied in the field of preparation of pharmaceutical impurity standard substances, can solve problems such as shortage of impurity reference substances, and achieves the effects of short preparation period, simple operation and reasonable design.

Pending Publication Date: 2022-03-18
SHENZHEN SUNGENING BIO-MEDICAL CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] An object of the present invention is to provide a kind of preparation method that has simple operation, short preparation cycle, low cost and environment-friendly brimonidine tartrate impurity E, solves the problem of this impurity reference substance shortage, simultaneously to brimonidine tartrate raw material Provide standard control substances for the quality control of finished medicines and preparations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of brimonidine tartrate impurity E
  • Preparation method of brimonidine tartrate impurity E
  • Preparation method of brimonidine tartrate impurity E

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1: Preparation of Intermediate Compound V

[0030] Type III (4.0 g, 17.8 mmol), IV (5.2 g, 17.8 mmol), silver (4.5 g, 17.8 mmol) and dimethyl sulfoxide (60 mL). The nitrogen was protected from temperature to 50 ° C, and the mixture was stirred for 20 hours. After lowering to room temperature, the reaction solution was poured into ice water, ethyl acetate (20 mL) was added twice, combined with the organic layer, saturated brine, washed twice, dry sodium sulfate, remove the solvent, residue silicone column layer Analysis was purified to give intermediate compound V (4.2 g, 11.5 mmol), yellow solid, yield of 64.6%.

Embodiment 2

[0031] Example 2: Preparation of lychane monogamonic impurity E

[0032] The intermediate compound V (1.83 g, 5.0 mmol) was dissolved in dichloromethane (27 mL), and trifluoroacetic acid (5.7 g, 50 mmol) was added under an ice bath, and then the mixture was stirred at room temperature 6 h. The solvent was concentrated, and the residue was purified by the reversed rapid column to obtain a tartarid monogamodic impurity E (1.20 g, 4.5 mmol), pale yellow solid, yield 90%.

[0033] The molecular formula of tartrate monogamodic impurity E: c 9 Hide 8 BRN 5 ;

[0034] The molecular weight of the tartrate monogamodic impurity E is: 266.10.

[0035] The mass spectrometer is used to analyze the synthetic product tartarid monogamonic impurity E E, and its MS spectrum is figure 1 As shown in the mass spectrum, the peak of m / z = 266.0 is the molecular ion peak M + H of 酒 莫 莫 定 E + , Consistent with the molecular weight of the lytectate monogamine E.

[0036] The nuclear magnetic resonance un...

Embodiment 3

[0042] Example 3: Preparation of Intermediate Compound V

[0043] To the 250 ml of three bottles, III (4.0 g, 17.8 mmol), IV (5.2 G, 17.8 mmol), silver fluorinated (2.26 g, 17.8 mmol) and N-methylpyrrolidone (40 mL) were added. The nitrogen removal was raised to 70 ° C, and the reaction was stirred for 16 hours. After lowering to room temperature, the reaction solution was poured into ice water, ethyl acetate (20 mL) was added twice, combined with the organic layer, saturated brine, washed twice, dry sodium sulfate, remove the solvent, residue silicone column layer Purification was purified to obtain an intermediate compound V (3.8 g, 10.4 mmol), yellow solid, yield of 58.4%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation method of a brimonidine tartrate impurity E. The preparation method belongs to the technical field of preparation of pharmaceutical impurity standard substances, and comprises the following steps: (1) dissolving a compound shown in a formula III and a compound shown in a formula IV in a first solvent, and reacting for a certain time at a first temperature under the catalysis of silver salt to obtain a compound shown in a formula V; and (2) performing deprotection on the compound shown in the formula V in a second solvent under the action of acid to obtain the brimonidine tartrate impurity E (formula II). The method has the advantages of simplicity in operation, short preparation period, low cost and environmental protection, solves the problem of shortage of impurity reference substances, and provides standard reference substances for quality control of brimonidine tartrate bulk drugs and preparation finished products.

Description

Technical field [0001] The present invention belongs to the preparation of drug impurity standards, and in particular, there is a method of preparation of a tartaric chloride monogamine impurity E. Background technique [0002] Tobolic acid brontol is Moniti, the chemical name is 5-bromine-N - (4, 5-dihydro-1H-imidazole-2-yl) -6-quinoxaline amine tartrate, molecular formula C 15 Hide 16 BRN 5 O 6 The molecular weight is 339.32, and the chemical structure formula I, the trade name is Alphagan, which is developed by ALLERG AN company, and launched for the first time in 1996. Tobolic acid monochidine is a new type of highly selective α 2 - Adregnostine receptor agonist, its mechanism is to selectively excite α 2 - Adrenaline receptor, which reducing the eye pressure. Clinically treatment of open-angle glaucoma. [0003] The quality of the drug is an important indicator of drug quality. The quality control of impurities is very important. The presence of impurities may directly affec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D241/42C07C51/41C07C59/255
CPCC07D241/42C07C51/41C07C59/255
Inventor 张亮李方林彭锦安
Owner SHENZHEN SUNGENING BIO-MEDICAL CO LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More